Who is sponsoring NCT00497003?

NCT00497003 is sponsored by Bispebjerg Hospital.

What condition does NCT00497003 study?

NCT00497003 studies Endothelial Function, Beta Blocker.

What drugs are being tested in NCT00497003?

Interventions: Treatment with either metoprolol or carvedilol.

What is the status of NCT00497003?

NCT00497003 is currently COMPLETED.

Last reviewed 2007-10-12 · How we verify

Effect of Beta Blocker Treatment on Endothelial Function in Patients With Type 2 Diabetes or Chronic Heart Failure

NCT00497003 Phase 4 COMPLETED

The aim of this study is to evaluate the effect of the two different beta blockers metoprolol and carvedilol on endothelial function in patients with either type two diabetes or chronic heart failure. Hypothesis: 1\* Carvedilol compared to metoprolol has a favourable effect on endothelial function. 2\* Carvedilol compared to metoprolol has a favourable effect on insulin stimulated endothelial function. The study is conducted as an open parallel group study. Endothelial function and insulin stimulated endothelial function was evaluated before and after a two months treatment period with either of the two beta blockers.

Details

Lead sponsor	Bispebjerg Hospital
Phase	Phase 4
Status	COMPLETED
Enrolment	50
Start date	2004-02
Completion	2007-10

Conditions

Endothelial Function
Beta Blocker

Interventions

Treatment with either metoprolol or carvedilol

Primary outcomes

Endothelial function and insulin stimulated endothelial function — 2 months

Countries

Denmark